Health Policies & Waivers

Set out below are some of the health and safety precautions that will be in place during our mini-conferences.

As the health and safety guidelines related to COVID-19 are continually developing globally, our health and safety precautions outlined below are subject to change.

We will inform the relevant mini-conference registrants of any changes to our health and safety precautions.

Effective July 12, 2021, our health and safety precautions are set out below:

• Vaccination Requirement—We require proof of vaccination at the time of the mini-conference/s for in-person attendance. To meet this requirement, mini-conference meeting registrants need to be “fully vaccinated.” To be fully vaccinated:
  • Two weeks or more must have passed since the date the Registrant received the second dose in a two-dose series vaccine; or
  • Two weeks or more must have passed since the date the mini-conference meeting registrant received a single-dose vaccine.
• Mini-conference meeting registrants who are unable to or are unwilling to produce proof of fully vaccinated status will be assumed to be NOT fully vaccinated.
• Acceptable Vaccinations—Acceptable international vaccinations include those currently recognized by WHO: Pfizer, Moderna, Janssen, AstraZeneca, Serum Institute of India, SinoVac, and SinoPharm.
• Negative COVID-19 Test—For the peace of mind of all mini-conference meeting registrants, in addition to the proof of vaccination at the time of the mini-conference, for you to access our mini-conference you will be required to provide a negative COVID-19 test result and the test was performed within 72 hours of the mini-conference. To meet this requirement, a negative COVID-19 Test result is:
  • an official NEGATIVE (Not Detected) PCR or Rapid-Antigen Test report that shows your bio-sample was collected, and the test was performed within 72-hours of the New York mini-conference and related event. OR,
  • a picture of a NEGATIVE test result from a home-use self-administered over-the-counter test (self-test kit), and the self-test was performed within 72-hours of the New York mini-conference’s Welcome Reception. If you plan to self-test, please visit the Center for Disease Control and Prevention’s information portal on self-testing.
• Social Distancing—Social distancing will be determined based on health and safety guidelines at the time and location of the mini-conferences.
• Protective Measures—We are working with all our mini-conference venues to ensure standard and reasonable protective measures in the mini-conference areas.
• Face Coverings or Masks—Mask mandates to be determined based on health and safety guidelines at the time and location of the mini-conferences. Effective November 8, 2021, usage of face-coverings or masks in the following cities are listed below:
  • New York mini-conference and preceding Welcome Reception: Face-coverings or masks are optional for individuals who are fully vaccinated when indoors. However, for the health and safety of you and your colleagues, masking is strongly encouraged.
  • Berlin mini-conference: Face-coverings or masks are required for individuals who are fully vaccinated when indoors. Currently, in Berlin, everyone must wear either a medical mask or a filtering facepiece (FFP2) mask indoors.
  • Los Angeles mini-conference: Face-coverings or masks is required for individuals who are fully vaccinated when indoors.
    Please continue to visit this page for new updates on face coverings and masking requirements.
• Limited Attendance—Capacity limitations in and around venues will follow local and facility recommendations and health and safety guidelines.
• Communications—We will have regular communications to all mini-conference meeting registrants about health and safety guidelines, where appropriate.

All mini-conference meeting registrants are required to adhere to all health and safety guidelines and policies implemented by INTA our partners and our hosts throughout all portions of the mini-conference/s. Mini-conference meeting registrants who do not comply with our COVID-19 health and safety precautions will not be permitted to enter or remain on mini-conference premises. Under these circumstances, registrants will not be provided with a refund. However, we welcome you to continue to enjoy our virtual Meeting program.

Verification of Proof of Vaccination
As noted above, we require proof of vaccination at the time of the mini-conference/s for in-person attendance.

INTA has contracted with a third-party health and safety team, Share My Health, to verify proof of vaccination before each of the mini-conferences through a secure web portal.

ShareMy.health is a HIPAA-compliant platform that will capture the required information from registrants securely and confidentially. However, while INTA does not receive any of the details you provide to ShareMy Health, we are made aware of whether an individual registrant is adequately compliant with our health and safety policies to attend our mini-conference and events associated with it.

The Share My Health team will be onsite in New York and Los Angeles to:

• Check that registrants have complied with our in-person Meeting requirements before a registrant is advanced to collect their registration badge.
• Provide support to any mini-conference meeting registrant who is feeling unwell.

Our vendor partner in Germany, CPO HANSER SERVICE GmbH, will provide similar onsite support as mentioned above.

Mini-conference meeting registrants understand and acknowledge that by this requirement the third-party health and safety team would be solely requesting voluntary disclosure of the mini-conference registrants’ fully vaccinated status, and pre-event COVID-19 test results. No other additional medical information is being sought. Mini-conference meeting registrants also understand and acknowledge that the fully vaccinated status and test results, if required, of the mini-conference meeting registrants shall be kept confidential.

Onsite Support
If you are feeling unwell, for your convenience and peace of mind, complimentary onsite COVID-19 Rapid Testing will be available at the mini-conference locations.

If a mini-conference meeting registrant tests positive at this time, they will not be allowed to return to the session room or participate in other events.

Registrant Duty to Self-Monitor
Mini-conference meeting registrants agree to self-monitor for signs and symptoms of COVID-19 (symptoms typically include fever, cough, and shortness of breath). Mini-conference meeting registrants understand and acknowledge that at every instance they join an in-person event at the mini-conferences, they are affirming that they are not experiencing any signs or symptoms of COVID-19.

We have instituted health and safety precautions consistent with the WHO guidance, local governmental agencies, health authorities, and best practices recommended by the facilities in locations where we will be hosting our mini-conferences. In some instances, we have gone above and beyond these guidelines to reduce the risk of exposure to, infection with, and spread of COVID-19.

However, despite our good faith efforts to establish and implement health and safety guidelines to minimize exposure to COVID-19, we cannot guarantee against potential exposure to and spread of COVID-19 at the mini-conferences. By choosing to voluntarily register and participate, the mini-conference meeting registrants understand, acknowledge, and assume the risk of potential exposure to COVID-19 at the mini-conferences.

BY REGISTERING FOR THE 2021 ANNUAL MEETING VIRTUAL+ INCLUDING THE MINI-CONFERENCE/S, YOU ARE RELEASING INTA, ITS STAFF, PARTNERS, EMPLOYEES, AND OTHER MINI-CONFERENCE REGISTRANTS FROM ALL CLAIMS, DEMANDS, DAMAGES, COSTS, OR LIABILITIES (COLLECTIVELY “CLAIMS”) ARISING FROM OR RELATING TO YOUR PARTICIPATION, ATTENDANCE OR OTHER INVOLVEMENT WITH OUR 2021 ANNUAL MEETING VIRTUAL+ INCLUDING THE MINI-CONFERENCE(S), INCLUDING, WITHOUT LIMITATION, ANY CLAIMS RELATED TO EXPOSURE TO, INFECTION WITH, OR SPREAD OF COVID-19 (ALSO KNOWN AS CORONAVIRUS).

YOU AGREE TO FOREGO ALL RIGHTS TO SUE INTA AND ITS PARTNERS FOR ANY REASON RELATED TO OR ARISING FROM YOUR PARTICIPATION, ATTENDANCE OR OTHER INVOLVEMENT WITH OUR 2021 ANNUAL MEETING VIRTUAL+ INCLUDING MINI-CONFERENCE(S), INCLUDING, WITHOUT LIMITATION, ANY CLAIMS RELATED TO EXPOSURE TO, INFECTION WITH, OR SPREAD OF COVID-19 (ALSO KNOWN AS CORONAVIRUS).

This Waiver and Release of Liability shall be construed broadly to provide a release and waiver to the maximum extent permissible under applicable law.